High materiality7/10
AbbVie price target raised to $300 from $295 at Wells Fargo
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Wells Fargo raises ABBV PT to $300 from $295; current price $249.45.
- WFC raises ABBV PT to $300
Key facts
- 01
Target: $300
- 02
Posted price: $249.45
- 03
Analyst firm: Wells Fargo
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.